Report Detail
Global Adrenoleukodystrophy Drugs Market Insights, Forecast to 2025
- RnM2849459 |
- 18 February, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The global Adrenoleukodystrophy Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Adrenoleukodystrophy Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Adrenoleukodystrophy Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Adrenoleukodystrophy Drugs in these regions.
This research report categorizes the global Adrenoleukodystrophy Drugs market by top players/brands, region, type and end user. This report also studies the global Adrenoleukodystrophy Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Applied Genetic Technologies Corp
Bluebird Bio Inc
MedDay SA
Minoryx Therapeutics sl
Pfizer Inc
ReceptoPharm Inc
SOM Biotech SL
Viking Therapeutics Inc
Market size by Product
Biotin
DRX-065
DUOC-01
Lenti-D
MIN-102
OP-101
Others
Market size by End User
Children
Adult
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Adrenoleukodystrophy Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Adrenoleukodystrophy Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Adrenoleukodystrophy Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Adrenoleukodystrophy Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Adrenoleukodystrophy Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Adrenoleukodystrophy Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Adrenoleukodystrophy Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Adrenoleukodystrophy Drugs Market Size Growth Rate by Product
- 1.4.2 Biotin
- 1.4.3 DRX-065
- 1.4.4 DUOC-01
- 1.4.5 Lenti-D
- 1.4.6 MIN-102
- 1.4.7 OP-101
- 1.4.8 Others
- 1.5 Market by End User
- 1.5.1 Global Adrenoleukodystrophy Drugs Market Size Growth Rate by End User
- 1.5.2 Children
- 1.5.3 Adult
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Adrenoleukodystrophy Drugs Market Size
- 2.1.1 Global Adrenoleukodystrophy Drugs Revenue 2014-2025
- 2.1.2 Global Adrenoleukodystrophy Drugs Sales 2014-2025
- 2.2 Adrenoleukodystrophy Drugs Growth Rate by Regions
- 2.2.1 Global Adrenoleukodystrophy Drugs Sales by Regions
- 2.2.2 Global Adrenoleukodystrophy Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Adrenoleukodystrophy Drugs Sales by Manufacturers
- 3.1.1 Adrenoleukodystrophy Drugs Sales by Manufacturers
- 3.1.2 Adrenoleukodystrophy Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Adrenoleukodystrophy Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Adrenoleukodystrophy Drugs Revenue by Manufacturers
- 3.2.1 Adrenoleukodystrophy Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Adrenoleukodystrophy Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Adrenoleukodystrophy Drugs Price by Manufacturers
- 3.4 Adrenoleukodystrophy Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Adrenoleukodystrophy Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Adrenoleukodystrophy Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Adrenoleukodystrophy Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Adrenoleukodystrophy Drugs Sales by Product
- 4.2 Global Adrenoleukodystrophy Drugs Revenue by Product
- 4.3 Adrenoleukodystrophy Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Adrenoleukodystrophy Drugs Breakdown Data by End User
6 North America
- 6.1 North America Adrenoleukodystrophy Drugs by Countries
- 6.1.1 North America Adrenoleukodystrophy Drugs Sales by Countries
- 6.1.2 North America Adrenoleukodystrophy Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Adrenoleukodystrophy Drugs by Product
- 6.3 North America Adrenoleukodystrophy Drugs by End User
7 Europe
- 7.1 Europe Adrenoleukodystrophy Drugs by Countries
- 7.1.1 Europe Adrenoleukodystrophy Drugs Sales by Countries
- 7.1.2 Europe Adrenoleukodystrophy Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Adrenoleukodystrophy Drugs by Product
- 7.3 Europe Adrenoleukodystrophy Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Adrenoleukodystrophy Drugs by Countries
- 8.1.1 Asia Pacific Adrenoleukodystrophy Drugs Sales by Countries
- 8.1.2 Asia Pacific Adrenoleukodystrophy Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Adrenoleukodystrophy Drugs by Product
- 8.3 Asia Pacific Adrenoleukodystrophy Drugs by End User
9 Central & South America
- 9.1 Central & South America Adrenoleukodystrophy Drugs by Countries
- 9.1.1 Central & South America Adrenoleukodystrophy Drugs Sales by Countries
- 9.1.2 Central & South America Adrenoleukodystrophy Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Adrenoleukodystrophy Drugs by Product
- 9.3 Central & South America Adrenoleukodystrophy Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Adrenoleukodystrophy Drugs by Countries
- 10.1.1 Middle East and Africa Adrenoleukodystrophy Drugs Sales by Countries
- 10.1.2 Middle East and Africa Adrenoleukodystrophy Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Adrenoleukodystrophy Drugs by Product
- 10.3 Middle East and Africa Adrenoleukodystrophy Drugs by End User
11 Company Profiles
- 11.1 Applied Genetic Technologies Corp
- 11.1.1 Applied Genetic Technologies Corp Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Products Offered
- 11.1.5 Applied Genetic Technologies Corp Recent Development
- 11.2 Bluebird Bio Inc
- 11.2.1 Bluebird Bio Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bluebird Bio Inc Adrenoleukodystrophy Drugs Products Offered
- 11.2.5 Bluebird Bio Inc Recent Development
- 11.3 MedDay SA
- 11.3.1 MedDay SA Company Details
- 11.3.2 Company Business Overview
- 11.3.3 MedDay SA Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 MedDay SA Adrenoleukodystrophy Drugs Products Offered
- 11.3.5 MedDay SA Recent Development
- 11.4 Minoryx Therapeutics sl
- 11.4.1 Minoryx Therapeutics sl Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Products Offered
- 11.4.5 Minoryx Therapeutics sl Recent Development
- 11.5 Pfizer Inc
- 11.5.1 Pfizer Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pfizer Inc Adrenoleukodystrophy Drugs Products Offered
- 11.5.5 Pfizer Inc Recent Development
- 11.6 ReceptoPharm Inc
- 11.6.1 ReceptoPharm Inc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 ReceptoPharm Inc Adrenoleukodystrophy Drugs Products Offered
- 11.6.5 ReceptoPharm Inc Recent Development
- 11.7 SOM Biotech SL
- 11.7.1 SOM Biotech SL Company Details
- 11.7.2 Company Business Overview
- 11.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 SOM Biotech SL Adrenoleukodystrophy Drugs Products Offered
- 11.7.5 SOM Biotech SL Recent Development
- 11.8 Viking Therapeutics Inc
- 11.8.1 Viking Therapeutics Inc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Products Offered
- 11.8.5 Viking Therapeutics Inc Recent Development
12 Future Forecast
- 12.1 Adrenoleukodystrophy Drugs Market Forecast by Regions
- 12.1.1 Global Adrenoleukodystrophy Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Adrenoleukodystrophy Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Adrenoleukodystrophy Drugs Market Forecast by Product
- 12.2.1 Global Adrenoleukodystrophy Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Adrenoleukodystrophy Drugs Revenue Forecast by Product 2019-2025
- 12.3 Adrenoleukodystrophy Drugs Market Forecast by End User
- 12.4 North America Adrenoleukodystrophy Drugs Forecast
- 12.5 Europe Adrenoleukodystrophy Drugs Forecast
- 12.6 Asia Pacific Adrenoleukodystrophy Drugs Forecast
- 12.7 Central & South America Adrenoleukodystrophy Drugs Forecast
- 12.8 Middle East and Africa Adrenoleukodystrophy Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Adrenoleukodystrophy Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Adrenoleukodystrophy Drugs . Industry analysis & Market Report on Adrenoleukodystrophy Drugs is a syndicated market report, published as Global Adrenoleukodystrophy Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Adrenoleukodystrophy Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
